Nonsmall cell lung cancer (NSCLC) tumorsin particular, frequently have oncogenic drivers arising from activatingmutations in EGFR, most commonly in-frame deletion of Exon19 (Exon19del)or L858R point mutation. Here, EGFR is linked to lung cancer.